Gilurytmal 50 mg/10 ml solution for injection Malta - English - Medicines Authority

gilurytmal 50 mg/10 ml solution for injection

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - ajmaline - solution for injection - ajmaline 5 mg/ml - cardiac therapy

Gilurytmal ® 50 mg/10 ml solution for injection Malta - English - Medicines Authority

gilurytmal ® 50 mg/10 ml solution for injection

ej busuttil ltd busuttil buildings, triq l-ghadam, central business district zone 1, birkirkara, cbd 1060, malta - solution for injection - ajmaline 50 mg/ml - cardiac therapy

PROSTIN VR PAEDIATRIC INJECTION 0.5 mgml Singapore - English - HSA (Health Sciences Authority)

prostin vr paediatric injection 0.5 mgml

pfizer private limited - alprostadil - injection - 0.5 mg/ml - alprostadil 0.5 mg/ml

Alprostadil Injection USP
   
 
 Rx only United States - English - NLM (National Library of Medicine)

alprostadil injection usp rx only

teva parenteral medicines, inc. - alprostadil (unii: f5td010360) (alprostadil - unii:f5td010360) - alprostadil 500 ug in 1 ml - alprostadil injection usp is indicated for palliative, not definitive, therapy to temporarily maintain the patency of the ductus arteriosus until corrective or palliative surgery can be performed in neonates who have congenital heart defects and who depend upon the patent ductus for survival. such congenital heart defects include pulmonary atresia, pulmonary stenosis, tricuspid atresia, tetralogy of fallot, interruption of the aortic arch, coarctation of the aorta, or transposition of the great vessels with or without other defects. in infants with restricted pulmonary blood flow, the increase in blood oxygenation is inversely proportional to pretreatment po2 values; that is, patients with low po2 values respond best, and patients with po2 values of 40 torr or more usually have little response. alprostadil injection usp should be administered only by trained personnel in facilities that provide pediatric intensive care. none.

NIMOTOP FOR INFUSION 0.02% Singapore - English - HSA (Health Sciences Authority)

nimotop for infusion 0.02%

bayer (south east asia) pte ltd - nimodipine - injection - 0.02% - nimodipine 0.02%

FLOQIN IV 2 mg/ml INFUSION (PARENTERAL) South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

floqin iv 2 mg/ml infusion (parenteral)

austell pharmaceuticals (pty) ltd - infusion (parenteral) - see ingredients - each 1,0 ml solution contains ciprofloxacin lactate equivalent to ciprofloxacin 2,0 mg

Nimotop 0.02% Solution for Infusion Malta - English - Medicines Authority

nimotop 0.02% solution for infusion

bayer plc - nimodipine - solution for infusion or injection - nimodipine 0.02 % (w/v) - calcium channel blockers

Nimotop New Zealand - English - Medsafe (Medicines Safety Authority)

nimotop

bayer new zealand limited - nimodipine 0.2 mg/ml - solution for infusion - 0.2 mg/ml - active: nimodipine 0.2 mg/ml excipient: citric acid ethanol macrogol 400 sodium citrate dihydrate water for injection - prophylaxis and treatment of ischaemic neurological deficits caused by cerebral vasospasm following subarachnoid haemorrhage of aneurysmal origin. patients should be in good neurological condition post-ictus.

NOREPINEPHRINE BITARTRATE INJECTION USP SOLUTION Canada - English - Health Canada

norepinephrine bitartrate injection usp solution

generic medical partners inc - norepinephrine (norepinephrine bitartrate) - solution - 1mg - norepinephrine (norepinephrine bitartrate) 1mg - alpha-and beta-adrenergic agonists